Sensory Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Neglected Immunotherapy-Responsive Sensory Neuropathy
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by XMLink in Journal of Clinical Neurology
- Vol. 20 (3) , 276-284
Abstract
Background and Purpose To report an improvement with immunotherapy in 34 (85%)/40 patients who required an immunotherapy among 56 patients with sensory chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods Sensory CIDP was diagnosed when two inclusion criteria are met: 1) acquired, chronic progressive or relapsing symmetrical or asymmetrical sensory polyneuropathy that had progressed for >2 months; and 2) definite electrophysiological and/or biopsy evidence of demyelinating neuropathy. Results Fifty-six patients with sensory CIDP were identified. Evidence of demyelination was obtained from by the routine motor nerve conduction study (NCS) in 39 (70%) patients, from a nerve biopsy in 10, and from a near-nerve needle sensory NCS in 7 patients. The most prominent laboratory abnormality was a high protein level in the cerebrospinal fluid in 21 (49%) of 43 tested patients. Immunotherapy was required in 41 (79%) of the 52 followed-up patients. An improvement with immunotherapy was observed in 36 (88%)/41 patients. In three patients, motor weakness developed in 5-8 years' follow-up period and so, their diagnosis was changed to CIDP. Conclusions Sensory CIDP is responded to an immunotherapy in 88% of the treated patients. Sensory CIDP was diagnosed by the routine motor NCS in 70% of patients and by a sural nerve biopsy in 18% of patients. Thus, sensory CIDP should be recognized as a treatable CIDP variant among the different types of "idiopathic sensory neuropathy."Keywords
This publication has 29 references indexed in Scilit:
- Ultra–high‐frequency ultrasound imaging of sural nerve: A comparative study with nerve biopsy in progressive neuropathiesMuscle & Nerve, 2020
- Diagnostic value of the near‐nerve needle sensory nerve conduction in sensory inflammatory demyelinating polyneuropathyMuscle & Nerve, 2017
- Multifocal sensory demyelinating neuropathy: Report of a caseMuscle & Nerve, 2017
- Sensory neuronopathiesMuscle & Nerve, 2015
- Sensory chronic inflammatory demyelinating polyneuropathy: An under-recognized entity?Muscle & Nerve, 2013
- Focal CIDP presenting as chronic progressive monomelic sensory neuropathyMuscle & Nerve, 2012
- Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: Evaluation of eight casesMuscle & Nerve, 2003
- Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: A long-term follow-up studyJournal of Neurology, 1999
- Late motor involvement in cases presenting as “chronic sensory demyelinating polyneuropathy”Muscle & Nerve, 1995
- Subacute Demyelinating Polyneuropathy Responding to Corticosteroid TreatmentArchives of Neurology, 1978